Health 201 · Outcomes Automated analyses of public data

Experimental. These analyses come from an automated pipeline that is still being tested. Every number is checked against the code that produced it and a person approves each brief before it appears here, but the methods, wording and presentation are not settled. If something looks wrong, unclear or missing, please tell us. [email protected]

Experimental · automated analysis · v02 · 2026-09-30

Ohio and US Age-Adjusted Overdose Death Rates, 1999-2018

This brief describes annual age-adjusted drug poisoning death rates per 100,000 residents in Ohio and the United States from 1999 to 2018. Ohio's rate rose from 4.15 in 1999 to 35.93 in 2018, with a peak of 46.35 in 2017. The US rate rose from 6.06 to 20.71, with a peak of 21.70 in 2017. Ohio started below the national rate (ratio 0.69 in 1999), fluctuated around it through 2009, and stayed above it from 2010 through 2018. The gap was widest in 2017, at 24.64 deaths per 100,000, or 2.14 times the national rate. It narrowed to 15.22 (ratio 1.73) in 2018. A segmented linear fit with a pre-specified 2010 breakpoint gave an Ohio slope of 1.01 per year before 2010 and 3.58 per year after. The US slope went from 0.68 to 1.25. These findings are associations from ecological, state-level data. The annual rates carry no confidence intervals, the 2017-2018 values may be provisional, and the 2018 decline should not be read as a turning point.

Ohio and US Age-Adjusted Overdose Death Rates, 1999-2018
Ohio and US Age-Adjusted Overdose Death Rates, 1999-2018

Results

Ohio series. The Ohio rate was 4.15 per 100,000 in 1999 (its minimum) and 35.93 in 2018, a rise of about 766%. It peaked at 46.35 in 2017. The US rate was 6.06 in 1999 (its minimum) and 20.71 in 2018, a rise of about 242%. It also peaked in 2017, at 21.70. Over the period the mean Ohio rate was 17.70 and the mean US rate was 12.42. Ohio compared with the US. In 1999 Ohio was 1.91 below the national rate (4.15 vs 6.06; ratio 0.69). The early comparison fluctuated. Ohio was still below the US in 2001 (ratio 0.95) and was essentially level in 2002 (ratio 1.00). It fell below again in 2003 (ratio 0.77), moved above from 2004, and dipped below once more in 2009 (ratio 0.91). Ohio has been above the national rate in every year since 2010 (16.09 vs 12.30; ratio 1.31 in 2010). Because the sign changed several times before 2010, no single crossover year is named. The gap widened steadily after that: 6.99 in 2013 (ratio 1.51), 13.62 in 2015 (ratio 1.84) and 19.34 in 2016 (ratio 1.98). It was widest in 2017, with Ohio at 46.35 against 21.70 nationally, a difference of 24.64 and a ratio of 2.14. In 2018 the difference was 15.22 and the ratio was 1.73. Across the whole period the gap grew by about 1.11 per 100,000 per year (p < 0.001, descriptive only). The full per-year table is on the results page. Slope change. Ohio's slope was 1.01 per year before the 2010 breakpoint and 3.58 per year after, a change of 2.57 (robust p < 0.001). The US slope went from 0.68 to 1.25, a change of 0.57 (robust p < 0.001). Ohio's slope change exceeded the US change by 2.01 per year (robust p < 0.001). The estimated level change at 2010 was -2.15 for Ohio (p = 0.48) and -2.27 for the US (p = 0.014). The fits explained a high share of variation (R-squared 0.93 for Ohio and 0.97 for the US). The Durbin-Watson statistics were 1.92 for Ohio and 1.40 for the US. Sensitivity. Moving the breakpoint changed the size of the Ohio slope change but not its direction. It was 1.90 at 2008, 2.27 at 2009, 2.84 at 2011 and 3.11 at 2012, all with robust p < 0.001. The US slope change was 0.25 at 2008 (robust p = 0.086), 0.40 at 2009, 0.73 at 2011 and 0.94 at 2012.

Background

Drug poisoning (overdose) deaths have been a major and changing contributor to mortality among US adults, and national analyses of poisoning-related deaths have documented long-run increases from 1999 onward [PMID 42065199]. State-level mortality among working-age adults differs across states, and published reports have linked those differences to state policy and political contexts [PMID 36288322] [PMID 37232531]. Ohio is often discussed as a state with a heavy overdose burden. This brief asks how Ohio's age-adjusted overdose death rate changed over 1999-2018 and how it compared with the national rate in each year. It also asks whether the Ohio-US gap widened. It describes patterns only and does not address why they occurred.

Methods

Source: CDC's data.cdc.gov, dataset 44rk-q6r2 (NCHS drug poisoning mortality), vintage 2020-09-08. This dataset was pinned by the caller and substituted for the suggested NCHS state-trends source. The input had 40 rows: 20 annual rows each for Ohio and the United States. No rows were suppressed and none were dropped. Time window: 1999 to 2018, annual, with each row treated as a discrete yearly value rather than a rolling window. Filters: sex Both Sexes, age All Ages, and race All Races-All Origins, which left one series per group with all 40 rows retained. The outcome is the age-adjusted death rate per 100,000 residents, standardised to the 2000 US population. The United States was the reference group. For each year the analysis reports the Ohio rate, the US rate, the absolute difference (Ohio minus US) and the rate ratio (Ohio divided by US), plus the years in which the sign of the difference changed. Each series was fitted with a segmented linear regression with a single breakpoint at 2010. The breakpoint was fixed in advance from the hypothesis and not chosen from the data. The fit gives slopes before and after the break, the change in slope and the change in level. Ordinary p-values are reported alongside Newey-West (autocorrelation-robust) p-values, and the robust ones are preferred. Sensitivity refits used breakpoints at 2008, 2009, 2011 and 2012. A linear trend on the annual difference and a test of whether Ohio's slope change differed from the US slope change were also run. All p-values are descriptive only.

Limitations

What the analysis excluded

Conclusion

Ohio's age-adjusted overdose death rate rose from 4.15 to 35.93 per 100,000 between 1999 and 2018, peaking at 46.35 in 2017. The national rate rose more slowly, from 6.06 to 20.71. Ohio fluctuated around the national rate through 2009 and stayed above it from 2010 onward. The gap in both absolute terms and ratio was widest in 2017 and remained large in 2018. The rise in Ohio's rate steepened after 2010 by more than the national rate did, though the exact size of the change depends on the breakpoint chosen. These are associations in aggregate data with provisional recent values, and they do not identify the reasons for the changes.

Findings

SeriesEstimatePrecision
state=Ohioslope +1.006 → +3.580 at 2010change p = 0.0001799
state=United Statesslope +0.685 → +1.250 at 2010change p = 0.001514

Comments and corrections

This is an experimental analysis and we want to hear where it falls short: a number that looks wrong, a limitation we missed, a better data source, or wording that overstates what the data show. Comments are read by a person and can lead to a revised version; earlier versions stay online.

Email a comment or write to [email protected] and mention ohio-vs-us-drug-poisoning-death-trend v02.

Automated review

Before publication this analysis was reviewed by an adversarial critic whose job is to find what is wrong with it, and then by a person who approved it for publication. Verdict: approve.

The analysis answers the question asked: annual Ohio and US age-adjusted rates for 1999-2018, a full per-year comparison table of 20 rows, and the absolute difference and rate ratio, with all 40 rows retained and none suppressed. The segmented fit is pre-specified at 2010, is labelled exploratory, and comes with breakpoint sensitivity and Newey-West errors. The plan's limitations are honest. Remaining problems are about how the results are worded, not the method, so they can be handled with caveats at write-up.

  • minor model-shape — A two-segment linear fit imposes one slope change at a single year. The Ohio series accelerates through 2014-2017 and then falls in 2018. The 2018 value is inside the post-break segment and pulls its slope down. The planned with/without-2018 refit is not shown in the results, and the sensitivity grid covers only 2008-2012, not the 2013-2014 breaks the plan named. Remedy: Report the refit without 2018 and the 2013/2014 breaks, or state that they were not run. Describe the shape mainly from the annual path and year-over-year changes, and treat the slope-change p-values as descriptive.
  • minor other — The early Ohio-US difference changes sign five times between 2002 and 2010, including a dip below the US rate in 2009, and there are no confidence intervals on the annual rates. The hypothesis that Ohio was below or near the national rate early and exceeded it later can only be supported loosely. A single crossover year would overstate what the data show. Remedy: Describe Ohio as fluctuating around the US rate through roughly 2001-2009 and persistently above it from 2010. Do not name a crossover year, and say that year-level noise cannot be quantified.
  • minor other — The US series includes Ohio, so the two series are not independent. The difference-trend and difference-slope-change p-values are also not valid formal tests, even with the HAC correction, given only 20 points. Remedy: Present the gap through the per-year difference and ratio. Report the trend p-values only as descriptive, with the non-independence stated.
  • minor provisional-data — The dataset was substituted for the suggested source, and the 2017-2018 values may be provisional or revised. The 2018 decline is the last point of the series and should not be read as a turning point. Remedy: State the dataset vintage and describe 2018 as a single observation of unknown durability. Check against final CDC WONDER values if possible.
  • minor unanswered — The planned drug-type stratifier (opioid, synthetic opioid, stimulant) was not obtained. The slope change in the 2010s therefore cannot be attributed to any drug class. Remedy: Keep the claim descriptive and state that drivers were not analysed.

Provenance

age-adjusted drug poisoning death rate per 100,000 outcome

Source
data-cdc-gov
Dataset
44rk-q6r2
Query
state = United States, sex = Both Sexes, age = All Ages, race = All Races-All Origins
Rows
40 returned, 0 suppressed and left missing
Fetched
2026-09-30T11:37:02
Substitution
dataset 44rk-q6r2 was pinned by the caller; the Scout's hint for 'age-adjusted drug poisoning death rate per 100,000' was 'NCHS drug poisoning mortality state trends / drug overdose death rates by state, 1999-2018, Ohio and United States rows'

Suppressed cells are never imputed or treated as zero. Raw outputs: results.json · data.csv

This is an automated analysis of publicly available, aggregate data. It is not a peer-reviewed publication, not a clinical guideline, and not medical advice. Findings describe associations in published data, never causes. Figures are produced by executed code, every number on this page is checked against that code's output, and a person reviewed and approved the brief before publication.